Indoco Remedies Ltd
Indoco Remedies Ltd (INDOCO) last traded at ₹226, a market capitalisation of ₹2,082 crore. Over the past 52 weeks the stock has ranged between ₹162 and ₹332. Indoco Remedies Ltd last reported results for the quarter ended Jun 2026, with sales of ₹468 crore and net profit of ₹65 crore. The next scheduled event is a record date on 10 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Indoco Remedies Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Indoco Remedies Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹468 cr, up 6.4% from ₹440 cr a year earlier. Net profit turned positive at ₹65 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 433 | 411 | 390 | 440 | 485 | 445 | 476 | 468 |
| Expenses | 392 | 399 | 391 | 422 | 442 | 414 | 426 | 426 |
| Operating profit | 40 | 12 | -1 | 18 | 43 | 32 | 50 | 41 |
| OPM % | 9% | 2.9% | -0.2% | 4.0% | 9% | 7% | 10% | 9% |
| Other income | 2 | 2 | 2 | 2 | 0 | -5 | 4 | 100 |
| Interest | 18 | 16 | 18 | 26 | 25 | 26 | 46 | 28 |
| Depreciation | 29 | 29 | 29 | 30 | 32 | 32 | 32 | 35 |
| Profit before tax | -5 | -31 | -46 | -37 | -14 | -31 | -25 | 78 |
| Tax % | 107% | -8% | -9% | -1% | -32% | -6% | -5% | 16% |
| Net profit | -10 | -28 | -41 | -36 | -9 | -29 | -24 | 65 |
| EPS (₹) | -1.04 | -2.86 | -4.38 | -3.88 | -0.86 | -3.23 | -2.34 | 7.04 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Indoco Remedies Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 1,242 | 1,541 | 1,669 | 1,817 | 1,665 | 1,845 | 1,873 |
| Operating profit | 225 | 328 | 288 | 245 | 100 | 142 | 165 |
| OPM % | 18% | 21% | 17% | 13% | 6% | 8% | 9% |
| Net profit | 93 | 155 | 142 | 97 | -78 | -99 | 3 |
| EPS (₹) | 10.10 | 16.80 | 15.44 | 10.68 | -7.99 | -10.31 | 0.61 |
TTM is the trailing twelve months to the most recent quarter.
Indoco Remedies Ltd growth and returns
- 10 Years
- 6%
- 5 Years
- 8%
- 3 Years
- 3%
- TTM
- 12%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- 33%
- 10 Years
- -3%
- 5 Years
- -13%
- 3 Years
- -12%
- 1 Year
- -23%
- 10 Years
- 5%
- 5 Years
- 5%
- 3 Years
- -2%
- Last Year
- -9%
Indoco Remedies Ltd shareholding pattern
Promoters held 58.86% at Jun 2026, broadly unchanged since Jun 2025. FIIs 1.27% and DIIs 17.68%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 58.76% | 58.80% | 58.90% | 58.90% | 58.90% | 58.90% | 58.86% | 58.86% |
| FIIs | 1.70% | 1.25% | 1.24% | 1.22% | 1.25% | 1.10% | 0.94% | 1.27% |
| DIIs | 18.25% | 18.91% | 18.75% | 18.96% | 18.16% | 18.15% | 18.15% | 17.68% |
| Public | 21.27% | 21.02% | 21.02% | 20.82% | 21.60% | 21.76% | 21.90% | 22.04% |
| No. of shareholders | 34,416 | 34,676 | 34,497 | 33,129 | 33,319 | 32,659 | 32,276 | 32,457 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Indoco Remedies Ltd events
The next scheduled event is a record date on 10 Sept 2026.
- Record dateRecord date for final dividend and cut-off date for AGM e-voting
- AGM79th Annual General Meeting and final dividend approval
See the full results calendar for every Indian company reporting in the next 30 days.
Indoco Remedies Ltd corporate filings
- Newspaper Advertisement-Information regarding 79th Annual General meeting and E-votingCompany Updatelow impact
Cruxal's analysis: Indoco Remedies Ltd has published a newspaper advertisement regarding the scheduling of…
Read the full analysis - Business Responsibility and Sustainability Reporting (BRSR)Otherslow impact
Cruxal's analysis: Indoco Remedies Ltd has submitted its Business Responsibility and Sustainability Report…
Read the full analysis - Annual Report for the financial year 2025-2026Otherslow impact
Cruxal's analysis: Indoco Remedies Ltd has filed its Annual Report for the financial year 2025-2026 as per…
Read the full analysis - Notice of 79th Annual General Meeting and Annual Report for the Financial year 2025-2026AGM/EGMlow impact
Cruxal's analysis: Indoco Remedies Limited has issued a formal notice for its 79th Annual General Meeting…
Read the full analysis - Notice of 79th Annual General Meeting and Annual Report for the financial year 2025-2026AGM/EGMlow impact
Cruxal's analysis: Indoco Remedies Limited has scheduled its 79th Annual General Meeting for September 17…
Read the full analysis - Intimation of Cut-Off Date for E voting, Book Closure and Record date for DividendCorp. Actionlow impact
Cruxal's analysis: Indoco Remedies Limited has formally notified the stock exchanges that 10th September…
Read the full analysis - Publication of Newspaper Advertisement- 79th Annual General Meeting to be held on 17th September, 2026 through VC/OAVMCompany Updatelow impact
Cruxal's analysis: Indoco Remedies has issued a newspaper advertisement confirming that its 79th Annual…
Read the full analysis - Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30-06-2026Company Updatehigh impact
Cruxal's analysis: Indoco Remedies Limited reported robust Q1 FY27 consolidated revenue growth of 8.2%…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Indoco Remedies Ltd
Cruxal reads every Indoco Remedies Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.